"10.1371_journal.pone.0105967","plos one","2014-09-02T00:00:00Z","Christopher Harrison; Helena Britt; Suzanne Garland; Lynne Conway; Alicia Stein; Marie Pirotta; Christopher Fairley","Family Medicine Research Centre, School of Public Health, University of Sydney, Sydney, Australia; Microbiology & Infectious Diseases, The Royal Women's Hospital, Parkville, Australia; Health Economics, bioCSL, Parkville, Victoria, Australia; bioCSL, Parkville, Victoria, Australia; Department of General Practice, University of Melbourne, Parkville, Victoria, Australia; Central Clinical School Monash University and Melbourne Sexual Health Centre, Carlton, Victoria, Australia","Conceived and designed the experiments: CH HB SG LC AS MP CF. Performed the experiments: CH HB. Analyzed the data: CH CF. Contributed reagents/materials/analysis tools: CH HB. Wrote the paper: CH. Reviewed and contributed to all iterations of the manuscript: HB SG LC AS MP CF.","The authors have read the journal's policy and have the following conflicts. C. Harrison, Prof. Britt and Prof. Pirotta claim no personal conflict of interest. Dr. Garland reports personal fees from CSL, GSK Merck cervical cancer advisory board, personal fees from GSK EXCEL program, grants from GSK, grants from Merck, grants from CSL, personal fees from GSK, MERCK, CSL, other from Stock/Stock options, personal fees from CSL, Merck, GSK, outside the submitted work. Both Dr. Conway and Stein are currently employed by BioCSL Pty Ltd, the manufacturer of Gardasil. Dr. Fairley reports grants and personal fees from Merck, outside the submitted work; and Dr. Fairley has received honoraria from CSL Biotherapies and Merck and research funding from CSL Biotherapies. Dr. Fairley owns shares in CSL Biotherapies the manufacturer for Gardasil. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2014","09","Christopher Harrison","CH",7,TRUE,7,2,2,1,TRUE,TRUE,FALSE,0,NA,FALSE
